• Real Time Chart Real Time Chart
  • Stock Profile Stock Profile
  • Financials As Reported

    • accession Number 0001558370-23-008510
    • accounts Payable Current 5,441,000
    • accounts Receivable Net Current 21,124,000
    • allocated Share Based Compensation Expense 4,572,000
    • amendment Flag false
    • assets 128,573,000
    • assets Current 107,162,000
    • cash And Cash Equivalents At Carrying Value 79,026,000
    • cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents 80,790,000
    • cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect --23,274,000
    • cik 1,393,434
    • city Area Code 781
    • common Stock Par Or Stated Value Per Share 0.0001
    • common Stock Shares Authorized 200,000,000
    • common Stock Shares Issued 77,516,638
    • common Stock Shares Outstanding 77,516,638
    • contract With Customer Liability 13,803,000
    • contract With Customer Liability Current 463,000
    • contract With Customer Liability Revenue Recognized 160,000
    • cost Of Goods And Services Sold 1,214,000
    • current Fiscal Year End Date --12-31
    • date Filed 2023-05-08
    • depreciation Depletion And Amortization 483,000
    • document Fiscal Period Focus Q1
    • document Fiscal Year Focus 2,023
    • document Period End Date 2023-03-31
    • document Transition Report false
    • document Type 10-Q
    • earnings Per Share Basic -0.39
    • earnings Per Share Diluted -0.39
    • employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized 26,118,000
    • employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition 1 P2Y6M29D
    • entity Address Address Line 1 24 Crosby Drive
    • entity Address City Or Town Bedford
    • entity Address Postal Zip Code 1,730
    • entity Address State Or Province MA
    • entity Central Index Key 1,393,434
    • entity Current Reporting Status Yes
    • entity Emerging Growth Company false
    • entity File Number 001-36554
    • entity Filer Category Non-accelerated Filer
    • entity Incorporation State Country Code DE
    • entity Interactive Data Current Yes
    • entity Name OCULAR THERAPEUTIX, INC
    • entity Registrant Name Ocular Therapeutix, Inc.
    • entity Shell Company false
    • entity Small Business true
    • entity Tax Identification Number 20-5560161
    • increase Decrease In Accounts Payable 1,025,000
    • increase Decrease In Accounts Receivable --201,000
    • increase Decrease In Contract With Customer Liability --160,000
    • increase Decrease In Inventories 292,000
    • interest Expense 1,768,000
    • interest Paid Net 701,000
    • inventory Net 2,266,000
    • irs Number 0
    • liabilities 118,862,000
    • liabilities And Stockholders Equity 128,573,000
    • liabilities Current 29,715,000
    • local Phone Number 357-4000
    • net Cash Provided By Used In Financing Activities 78,000
    • net Cash Provided By Used In Investing Activities --3,379,000
    • net Cash Provided By Used In Operating Activities --19,973,000
    • net Income Loss --30,318,000
    • nonoperating Income Expense --7,769,000
    • operating Income Loss --22,549,000
    • operating Lease Liability Current 1,818,000
    • operating Lease Liability Noncurrent 8,114,000
    • operating Lease Right Of Use Asset 7,625,000
    • other Liabilities Noncurrent 100,000
    • other Nonoperating Income Expense --1,000
    • payments To Acquire Property Plant And Equipment 3,379,000
    • period End 1,680,220,800,000
    • period Start 1,672,531,200,000
    • property Plant And Equipment Net 12,022,000
    • report Link https://www.sec.gov/Archives/edgar/data/1393434/000155837023008510/ocul-20230331x10q_htm.xml
    • research And Development Expense 14,747,000
    • retained Earnings Accumulated Deficit --647,160,000
    • revenue From Contract With Customer Excluding Assessed Tax 13,374,000
    • share Based Compensation 4,572,000
    • stockholders Equity 9,711,000
    • trading Symbol OCUL
    • update 1970-01-01
    • weighted Average Number Of Diluted Shares Outstanding 77,386,287
    • weighted Average Number Of Shares Outstanding Basic 77,386,287
    • id REPORTED_FINANCIALS
    • key OCUL
    • subkey 10-Q
    • date 2023-05-08
    • updated 2023-05-09
  • Symbol Info Symbol Info
  • Symbol Over View Symbol Over View
  • Technical Analysis Technical Analysis

OCUL stock fundamentals - financials as reported

Financials As Reported

  • accession Number 0001558370-23-008510
  • accounts Payable Current 5,441,000
  • accounts Receivable Net Current 21,124,000
  • allocated Share Based Compensation Expense 4,572,000
  • amendment Flag false
  • assets 128,573,000
  • assets Current 107,162,000
  • cash And Cash Equivalents At Carrying Value 79,026,000
  • cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents 80,790,000
  • cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect --23,274,000
  • cik 1,393,434
  • city Area Code 781
  • common Stock Par Or Stated Value Per Share 0.0001
  • common Stock Shares Authorized 200,000,000
  • common Stock Shares Issued 77,516,638
  • common Stock Shares Outstanding 77,516,638
  • contract With Customer Liability 13,803,000
  • contract With Customer Liability Current 463,000
  • contract With Customer Liability Revenue Recognized 160,000
  • cost Of Goods And Services Sold 1,214,000
  • current Fiscal Year End Date --12-31
  • date Filed 2023-05-08
  • depreciation Depletion And Amortization 483,000
  • document Fiscal Period Focus Q1
  • document Fiscal Year Focus 2,023
  • document Period End Date 2023-03-31
  • document Transition Report false
  • document Type 10-Q
  • earnings Per Share Basic -0.39
  • earnings Per Share Diluted -0.39
  • employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized 26,118,000
  • employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition 1 P2Y6M29D
  • entity Address Address Line 1 24 Crosby Drive
  • entity Address City Or Town Bedford
  • entity Address Postal Zip Code 1,730
  • entity Address State Or Province MA
  • entity Central Index Key 1,393,434
  • entity Current Reporting Status Yes
  • entity Emerging Growth Company false
  • entity File Number 001-36554
  • entity Filer Category Non-accelerated Filer
  • entity Incorporation State Country Code DE
  • entity Interactive Data Current Yes
  • entity Name OCULAR THERAPEUTIX, INC
  • entity Registrant Name Ocular Therapeutix, Inc.
  • entity Shell Company false
  • entity Small Business true
  • entity Tax Identification Number 20-5560161
  • increase Decrease In Accounts Payable 1,025,000
  • increase Decrease In Accounts Receivable --201,000
  • increase Decrease In Contract With Customer Liability --160,000
  • increase Decrease In Inventories 292,000
  • interest Expense 1,768,000
  • interest Paid Net 701,000
  • inventory Net 2,266,000
  • irs Number 0
  • liabilities 118,862,000
  • liabilities And Stockholders Equity 128,573,000
  • liabilities Current 29,715,000
  • local Phone Number 357-4000
  • net Cash Provided By Used In Financing Activities 78,000
  • net Cash Provided By Used In Investing Activities --3,379,000
  • net Cash Provided By Used In Operating Activities --19,973,000
  • net Income Loss --30,318,000
  • nonoperating Income Expense --7,769,000
  • operating Income Loss --22,549,000
  • operating Lease Liability Current 1,818,000
  • operating Lease Liability Noncurrent 8,114,000
  • operating Lease Right Of Use Asset 7,625,000
  • other Liabilities Noncurrent 100,000
  • other Nonoperating Income Expense --1,000
  • payments To Acquire Property Plant And Equipment 3,379,000
  • period End 1,680,220,800,000
  • period Start 1,672,531,200,000
  • property Plant And Equipment Net 12,022,000
  • report Link https://www.sec.gov/Archives/edgar/data/1393434/000155837023008510/ocul-20230331x10q_htm.xml
  • research And Development Expense 14,747,000
  • retained Earnings Accumulated Deficit --647,160,000
  • revenue From Contract With Customer Excluding Assessed Tax 13,374,000
  • share Based Compensation 4,572,000
  • stockholders Equity 9,711,000
  • trading Symbol OCUL
  • update 1970-01-01
  • weighted Average Number Of Diluted Shares Outstanding 77,386,287
  • weighted Average Number Of Shares Outstanding Basic 77,386,287
  • id REPORTED_FINANCIALS
  • key OCUL
  • subkey 10-Q
  • date 2023-05-08
  • updated 2023-05-09